Abstract:β-Arrestins are a family of regulatory and scaffold proteins functioning in signal transduction of G protein-coupled receptors including opioid receptors. Upon agonist stimulation, β-arrestins bind to opioid receptors phosphorylated by G protein-coupled receptor kinases and promote receptor internalization and desensitization. Studies indicated that β-arrestins are required in the development of morphine tolerance in mice. In the current study, we investigated the potential regulatory effects of morphine administration on β-arrestin 1 and β-arrestin 2 mRNA levels in different brain regions in rat using in situ hybridization method. Our results showed that the acute morphine administration (10 mg/kg) resulted in approximately 30% reduction in both β-arrestin 1 and β-arrestin 2 mRNA levels in hippocampus while the chronic morphine treatment (10 mg/kg, b.i.d., for 9 days) caused no significant change in level of either β-arrestin mRNA. In locus coeruleus, both acute and chronic morphine treatments resulted in significant decreases (over 50%) in β-arrestin 1 mRNA level but failed to induce any change in the level of β-arrestin 2 gene expression. The acute morphine administration had no significant effect on β-arrestin 1 or β-arrestin 2 mRNA level in periaqueductal gray and cerebral cortex. However, after chronic morphine treatment, β-arrestin 2 mRNA level decreased by 40% in periaqueductal gray and increased by 25% in cerebral cortex, in strong contrast to the unchanged β-arrestin 1 mRNA level in these two brain regions. Furthermore, spontaneous or naloxone-precipitated withdrawal of morphine that did not affect the level of β-arrestin 1 mRNA resulted in an aberrant increase (100% over control) in β-arrestin 2 mRNA level in hippocampus. Our results thus demonstrated for the first time that opiate administration regulates level of β-arrestin mRNAs in brain and the expression of β-arrestin 1 and β-arrestin 2 subtypes is differentially regulated in locus coeruleus, periaqueductal gray, and cerebral cortex by morphine. These data suggest that β-arrestin 1 and β-arrestin 2 may play different roles in the development of opioid tolerance and dependence.

Post-Transcriptional Regulation of Mouse κ-Opioid Receptor Expression

Regulation of Mouse Kappa Opioid Receptor Gene Expression by Different 3 '-Untranslated Regions and the Effect of Retinoic Acid

Mouse Kappa-Opioid Receptor Mrna Differential Transport in Neurons

The Opioid Ligand Binding of Human Mu-Opioid Receptor is Modulated by Novel Splice Variants of the Receptor.

Differential Expressions of the Alternatively Spliced Variant Mrnas of the Μ Opioid Receptor Gene, OPRM1, in Brain Regions of Four Inbred Mouse Strains.

Regulation of Mouse Kappa Opioid Receptor Gene Expression by Retinoids

μ-Opioid receptor transcriptional variants in the murine forebrain and spinal cord

Morphine Modulates the Expression of Mu-Opioid Receptor Exon 5-Associated Full-Length C-terminal Splice Variants by Upregulating Mir-378A-3p

Sex Associated Differential Expressions of the Alternatively Spliced Variants mRNA of OPRM1 in Brain Regions of C57BL/6 Mouse.

Distribution of κ Opioid Receptor mRNA in Adult Mouse Brain: An in Situ Hybridization Histochemistry Study

Morphine Regulates Expression Ofμ-Opioid Receptor MOR-1A, an Intron-Retention Carboxyl Terminal Splice Variant of Theμ-Opioid Receptor (OPRM1) Gene Via Mir-103/Mir-107

Exploring the Putative Mechanism of Allosteric Modulations by Mixed-Action Kappa/mu Opioid Receptor Bitopic Modulators.

Alternative Pre-mRNA Splicing of the Mu Opioid Receptor Gene, OPRM1: Insight into Complex Mu Opioid Actions

Alternatively Spliced Mu Opioid Receptor C Termini Impact the Diverse Actions of Morphine

The role of transcription factors Sp1 and YY1 in proximal promoter region in initiation of transcription of the mu opioid receptor gene in human lymphocytes.

Regulation of MOR‐1A, an Intron‐retention Splice Variant of the Mu Opioid Receptor (OPRM1) Gene, by Mir‐107

Computational Insights into the Molecular Mechanisms of Differentiated Allosteric Modulation at the Mu Opioid Receptor by Structurally Similar Bitopic Modulators

The Potential Promoter Regions on the 5 ' Flank Sequence of the Mu Opioid Receptor Gene in Lymphocytes

Differential regulation of β-arrestin 1 and β-arrestin 2 gene expression in rat brain by morphine

Molecular Modeling on Kappa Opioid Receptor and Its Interaction with Nonpeptide Kappa Opioid Agonists